Clinical Trials Logo

Clinical Trial Summary

After thyroid surgery, 0.6 to 4% of patients develop postoperative bleeding. 90% of this postoperative bleeding occurs within the first 48 hours. Most of the time, the complications are rapidly progressing and require immediate attention. Up to 0.6% of patients with postoperative bleeding die. In a clinical study with postoperative pressure measurements it could be shown that postoperative bleeding without interruption leads to a continuous increase in pressure in the neck, as is observed when coughing and pressing. Systematic invasive pressure measurement in the thyroid compartment after surgery might detect a continuous increase in pressure which is often caused by a growing haematoma, indicating serious post-surgery bleeding at a much earlier time compared to state of the art diagnostic workflow. n routine clinical care, detection of serious haemorrhage depends on the patients alerting symptoms even if post-operative intermittent monitoring of vital parameters and wound conditions is performed according to current medical guidelines [18] and local instructions. Device-based, continuous haemorrhage detection within 36 to 48 hours after surgery would allow to objectively measure an increase in cervical pressure before symptoms occur, i.e. early detection of risk leading to timely therapeutic actions. Thus, the risk of serious complications like hypoxic brain damage and death caused by post-operative haemorrhage is minimized. In addition, the intervention team would be able to fine-tune necessary actions during the rescue procedure based on objective pressure values, e.g. the decision to open cutaneous sutures immediately or later in the operation theatre, and therefore reduce additional perioperative morbidity and increase patients' safety.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04845867
Study type Observational [Patient Registry]
Source ISAR-M GmbH
Contact Olivia Fedunik-Brehm
Phone +491735667761
Email olivia.fedunik-brehm@isar-m.com
Status Not yet recruiting
Phase
Start date July 1, 2021
Completion date August 31, 2022

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04085913 - Exparel Injection Effect on Postoperative Opioid Usage Early Phase 1
Completed NCT04647006 - Comparison of TOETVA and Conventional Thyroidectomy N/A
Completed NCT04763122 - Thyroid Cancer in United Arab Emirates
Completed NCT05323539 - Comparison of Thyroid Volumes in Patients With and Without Endometrioma N/A
Recruiting NCT04160637 - Is There Benefit From Early Postoperative PTH Monitoring?
Completed NCT03597659 - PheWAS of a Polygenic Predictor of Thyroid Function
Completed NCT03430141 - A Nutritarian Study to Evaluate the Effectiveness of Lifestyle Changes in Chronic Disease Prevention, Especially Cancer N/A
Recruiting NCT04115514 - Treatment of ARDS With Instilled T3 Phase 2
Recruiting NCT04623801 - Laser Ablation of Papillary Thyroid Microcarcinoma Phase 2
Recruiting NCT03754621 - Upper Limit for TSH of First and Second Trimester Pregnancy in Turkey
Withdrawn NCT03060499 - Post Thyroidectomy Myocardial Function
Completed NCT05276271 - The Effect of Levetiracetam on Lipid Profile in Children
Recruiting NCT04014660 - Prevention av Autoimmunitet Med Laktobaciller N/A
Completed NCT02304172 - The Efficacy and Safety of Thunderbeat in Thyroid Surgery N/A
Recruiting NCT04571736 - Pilot Study for Thyroid Surgery by Preoperative Video Support and Personalized and Secure Web Platform N/A
Recruiting NCT05510609 - Three-dimensional Ultrasonography Thyroid Volume Measurement. N/A
Active, not recruiting NCT05328076 - Parathyroid Vascularization During Total Thyroidectomy Using Indocyanine Green Angiography
Not yet recruiting NCT06377943 - The Interaction Between Resting Metabolic Rate, Physical Activity and Thyroid Hormone in Females
Recruiting NCT03933358 - Effect of Thyroid Hormone on Post-Myocardial Infarction Remodeling and Prognosis in STEMI Patients
Active, not recruiting NCT02681328 - Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules